HRP20200763T1 - Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21 - Google Patents

Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21 Download PDF

Info

Publication number
HRP20200763T1
HRP20200763T1 HRP20200763TT HRP20200763T HRP20200763T1 HR P20200763 T1 HRP20200763 T1 HR P20200763T1 HR P20200763T T HRP20200763T T HR P20200763TT HR P20200763 T HRP20200763 T HR P20200763T HR P20200763 T1 HRP20200763 T1 HR P20200763T1
Authority
HR
Croatia
Prior art keywords
glp
inhibitor
function
agonist
intended
Prior art date
Application number
HRP20200763TT
Other languages
English (en)
Croatian (hr)
Inventor
Ken COPPIETERS
Matthias Von Herrath
Tamar BOURSALIAN
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2015/059811 external-priority patent/WO2015169789A1/en
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HRP20200763T1 publication Critical patent/HRP20200763T1/hr

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HRP20200763TT 2014-05-07 2020-05-11 Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21 HRP20200763T1 (hr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461989841P 2014-05-07 2014-05-07
EP14169596 2014-05-23
EP14189732 2014-10-21
PCT/EP2015/059811 WO2015169789A1 (en) 2014-05-07 2015-05-05 Treatment of diabetes type 1 using glp-1 and anti-il-21
EP15720982.6A EP3139948B1 (en) 2014-05-07 2015-05-05 Treatment of diabetes type 1 using glp-1 and anti-il-21

Publications (1)

Publication Number Publication Date
HRP20200763T1 true HRP20200763T1 (hr) 2020-07-24

Family

ID=70609983

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200763TT HRP20200763T1 (hr) 2014-05-07 2020-05-11 Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21

Country Status (6)

Country Link
JP (1) JP6824373B2 (da)
DK (1) DK3139948T3 (da)
ES (1) ES2791879T3 (da)
HR (1) HRP20200763T1 (da)
HU (1) HUE048860T2 (da)
PT (1) PT3139948T (da)

Also Published As

Publication number Publication date
PT3139948T (pt) 2020-05-22
HUE048860T2 (hu) 2020-09-28
ES2791879T3 (es) 2020-11-06
JP2020073501A (ja) 2020-05-14
DK3139948T3 (da) 2020-05-25
JP6824373B2 (ja) 2021-02-03

Similar Documents

Publication Publication Date Title
HRP20202024T1 (hr) Cd3-vežuća domena
HRP20201353T1 (hr) Agonisti glukagonskog receptora
HRP20170905T1 (hr) Antikancerogeni fuzijski protein
HRP20170890T1 (hr) Suagonisti glukagonskog/glp-1 receptora
JP2017532313A5 (da)
AR093903A1 (es) Coagonistas de glucagon y glp-1 para el tratamiento de la obesidad
JP2018537415A5 (da)
PE20170954A1 (es) Compuestos co-agonistas de gip y glp-1
JP2017529067A5 (da)
IL299282A (en) Enhanced variable complexes of immunoglobulins
JP2015509091A5 (da)
PE20240215A1 (es) Derivado de glucagon y una composicion que comprende un conjugado de accion prolongada del mismo
JP2016536322A5 (da)
JP2016529229A5 (da)
NZ764889A (en) Composition for treating diabetes mellitus comprising insulin and a glp-1/glucagon dual agonist
AR065506A1 (es) Anticuerpos antagonistas ox40 y su uso en el tratamiento de enfermedades
PE20220938A1 (es) Compuestos agonistas de gipr
JP2019510739A5 (da)
PE20190743A1 (es) Metodos para el tratamiento de la atrofia muscular y enfermedad osea con el uso de proteinas trap hibridas novedosas del ligando actriib
WO2013181087A3 (en) Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy
HRP20150664T1 (hr) Antikancerogeni fuzijski protein
HRP20231118T1 (hr) Sintetizirani polipeptidi koji vežu transferinske receptore
AR107290A1 (es) ANTICUERPOS PEPTÍDICOS b AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
CL2007001835A1 (es) Metodos para la preparacion de peptidos insulinotropicos, particularmente el peptido similar a glucagon 1 (glp-1) y los homologos del mismo, utilizando procesos en fase solida y en solucion; fragmento peptidico util en la preparacion del peptido insu
WO2016057529A3 (en) Biphasic single-chain insulin analogues